Immix Biopharma (IMMX) Current Assets (2020 - 2026)
Immix Biopharma (IMMX) posted Current Assets of $92.3 million for Q1 2026, down 8.85% sequentially from $101.2 million in Q4 2025, and up 449.93% YoY from $16.8 million in Q1 2025.
Immix Biopharma (IMMX) Current Assets (2020 - 2026) Analysis & Trends
Immix Biopharma has reported Current Assets for 7 years, with the latest figure at $92.3 million in Q1 2026.
- Quarterly Current Assets rose 449.93% year-over-year to $92.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $92.3 million (up 449.93% YoY) and the FY2025 annual result came in at $101.2 million, up 401.23% from the prior year.
- Current Assets retreated to $92.3 million in Q1 2026 per IMMX's latest filing, from $101.2 million in the prior quarter.
- Over five years, Current Assets peaked at $101.2 million in Q4 2025 and troughed at $12.3 million in Q2 2025.
- A 5-year average of $28.5 million and a median of $19.8 million in 2023 frame the typical range for Current Assets.
- The sharpest annual moves came in 2025 and 2026: Current Assets tumbled 54.9% in 2025, then soared 449.93% in 2026.
- Over 5 years, Current Assets stood at $14.9 million in 2022, then soared by 32.82% to $19.8 million in 2023, then increased by 2.07% to $20.2 million in 2024, then surged by 401.23% to $101.2 million in 2025, then slipped by 8.85% to $92.3 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $92.3 million, $101.2 million, and $16.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Immix Biopharma | 784.75 Mn | 784.75 Mn | - | 233.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 233.79 Mn |
| Mar 31, 2026 | 92.27 Mn |
| Dec 31, 2025 | 101.24 Mn |
| Sep 30, 2025 | 16.58 Mn |
| Jun 30, 2025 | 12.33 Mn |
| Mar 31, 2025 | 16.78 Mn |
| Dec 31, 2024 | 20.20 Mn |
| Sep 30, 2024 | 22.76 Mn |
| Jun 30, 2024 | 27.33 Mn |
| Mar 31, 2024 | 32.92 Mn |
| Dec 31, 2023 | 19.79 Mn |
| Sep 30, 2023 | 22.33 Mn |
| Jun 30, 2023 | 15.51 Mn |
| Mar 31, 2023 | 13.03 Mn |
| Dec 31, 2022 | 14.90 Mn |
| Sep 30, 2022 | 17.39 Mn |
| Jun 30, 2022 | 19.08 Mn |
| Mar 31, 2022 | 20.01 Mn |
| Dec 31, 2021 | 18.19 Mn |
| Dec 31, 2020 | 532,236.00 |